Workflow
Photochemical lysis (PCL) technology
icon
Search documents
PCI Biotech announces discontinuation of development of the PCL technology and evaluation of future operations
Globenewswire· 2025-08-18 18:40
Oslo (Norway), 18 August 2025 – PCI Biotech Holding ASA (PCI Biotech, OSE:PCIB) today announces the discontinuation of development of the photochemical lysis (PCL) technology for viral vector manufacturing. Today’s decision is primarily based on the insufficient progress towards the 2025 goal of demonstrating improved yield in mini benchtop bioreactors. Achieving successful end-to-end results in small bioreactors is a critical risk-reducing milestone for further development. Following the progress reported ...